(Q36272704)

English

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Fearon DT

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Austen KF

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Ruddy S

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 December 1973

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

138

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1305-1313

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

30 September 2017

ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

30 September 2017

The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

30 September 2017

Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

29 June 2018

Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

29 June 2018

A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

29 June 2018

Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

29 June 2018

C3 proactivator convertase and its mode of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

29 June 2018

EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

22 September 2018

C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2139460

22 September 2018

Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional relationship of factor B in the properdin system to C3 proactivator of human serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.138.6.1305

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36272704&oldid=1622724184"